Ozempic and Wegovy are no longer in shortage, FDA says
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday. The update about the popular semaglutide injections from drug manufacturer Novo Nordisk follows just two months ...
Ozempic, Wegovy Shortage Is Officially Over
The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker Novo Nordisk, confirmed that supply now meets or exceeds both the current and projected U.S. demand. The injectable formulation of the GLP-1 receptor agonist has been in shortage since August 2022 due to increased demand.
Shares of wellness-product platform Hims & Hers Health Inc. tumbled on Friday after the Food and Drug Administration said the ...
The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs ...
American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...
Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...
People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol. A new ...
A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol ...
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
First for Women on MSN2d
Does Ozempic Make Food Taste Different? How It Quiets CravingsWe're hardwired to crave fat and sugar. This drive for calorie-dense foods is a big part of how our ancient ancestors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback